Skip to main content
. 2007 Jul 25;104(31):12837–12842. doi: 10.1073/pnas.0703342104

Fig. 2.

Fig. 2.

CD4+ T cell response to ESO157–170 vaccine. (A) There is a significant relationship between the number of vaccines and the maximal number of detectable ESO157–170-reactive CD4+ T cells (P = 0.002) when data from all patients are examined cumulatively. (B) CD4+ T cells were stimulated with ESO157–170 peptide and tested against target cells (T-APC loaded with ESO157–170 peptide or irrelevant peptide Flu NP206–229, Flu NP) by IFN-γ ICS.

HHS Vulnerability Disclosure